US$ 22.49
moa of glp 1 GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes GLP-1 | Pancreapedia
Description
Why Generic Biologic Is a Scientific Contradiction The conceptual gap between a small-molecule generic and a biosimilar is larger than most non-technical stakeholders appreciate, and the strategic implications of that gap are enormous

To continue exploring our contents on obesity, visit our knowledge hub

10.2337/diabetes.54.1.146 36

Accessed April 8, 2026 at In Brief: New FDA Warning of Pulmonary Aspiration with GLP-1 Receptor Agonists

[DOI] [PubMed] [Google Scholar] 154.Narayana SK, Talab SK, Elrishi MA
Zheng H, Reiner DJ, Hayes MR, Rinaman L
